Biologically active compounds from marine organisms in the strategies for combating coronaviruses
- PMID: 33364539
- PMCID: PMC7755586
- DOI: 10.3934/microbiol.2020028
Biologically active compounds from marine organisms in the strategies for combating coronaviruses
Abstract
Despite the progress made in immunization and drug development, so far there are no prophylactic vaccines and effective therapies for many viral infections, including infections caused by coronaviruses. In this regard, the search for new antiviral substances continues to be relevant, and the enormous potential of marine resources are a stimulus for the study of marine compounds with antiviral activity in experiments and clinical trials. The highly pathogenic human coronaviruses-severe acute respiratory syndrome-related coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) remain a serious threat to human health. In this review, the authors hope to bring the attention of researchers to the use of biologically active substances of marine origin as potential broad-spectrum antiviral agents targeting common cellular pathways and various stages of the life cycle of different viruses, including coronaviruses. The review has been compiled using references from major databases such as Web of Science, PubMed, Scopus, Elsevier, Springer and Google Scholar (up to June 2020) and keywords such as 'coronaviruses', 'marine organisms', 'biologically active substances', 'antiviral drugs', 'SARS-CoV', 'MERS-CoV', 'SARS-CoV-2', '3CLpro', 'TMPRSS2', 'ACE2'. After obtaining all reports from the databases, the papers were carefully analysed in order to find data related to the topic of this review (98 references). Biologically active substances of marine origin, such as flavonoids, phlorotannins, alkaloids, terpenoids, peptides, lectins, polysaccharides, lipids and others substances, can affect coronaviruses at the stages of penetration and entry of the viral particle into the cell, replication of the viral nucleic acid and release of the virion from the cell; they also can act on the host's cellular targets. These natural compounds could be a vital resource in the fight against coronaviruses.
Keywords: MERS-CoV; SARS-CoV; SARS-CoV-2; antiviral drugs; biologically active substances; coronaviruses; marine organisms.
© 2020 the Author(s), licensee AIMS Press.
Conflict of interest statement
Conflicts of interest: The authors declare no conflict of interest.
Figures
Similar articles
-
Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.Drug Resist Updat. 2020 Dec;53:100721. doi: 10.1016/j.drup.2020.100721. Epub 2020 Aug 26. Drug Resist Updat. 2020. PMID: 33132205 Free PMC article. Review.
-
Multifaceted role of natural sources for COVID-19 pandemic as marine drugs.Environ Sci Pollut Res Int. 2022 Jul;29(31):46527-46550. doi: 10.1007/s11356-022-20328-5. Epub 2022 May 4. Environ Sci Pollut Res Int. 2022. Retraction in: Environ Sci Pollut Res Int. 2024 Mar;31(15):23299. doi: 10.1007/s11356-024-32891-0. PMID: 35507224 Free PMC article. Retracted. Review.
-
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29. Antiviral Res. 2015. PMID: 25554382 Free PMC article. Review.
-
Broad-spectrum coronavirus antiviral drug discovery.Expert Opin Drug Discov. 2019 Apr;14(4):397-412. doi: 10.1080/17460441.2019.1581171. Epub 2019 Mar 8. Expert Opin Drug Discov. 2019. PMID: 30849247 Free PMC article. Review.
-
Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.J Virol. 2016 Sep 12;90(19):8924-33. doi: 10.1128/JVI.01429-16. Print 2016 Oct 1. J Virol. 2016. PMID: 27466418 Free PMC article.
Cited by
-
Docking-based virtual screening and identification of potential COVID-19 main protease inhibitors from brown algae.S Afr J Bot. 2021 Dec;143:428-434. doi: 10.1016/j.sajb.2021.06.033. Epub 2021 Jul 1. S Afr J Bot. 2021. PMID: 34226782 Free PMC article.
-
Recent Progress in Antioxidant Active Substances from Marine Biota.Antioxidants (Basel). 2022 Feb 22;11(3):439. doi: 10.3390/antiox11030439. Antioxidants (Basel). 2022. PMID: 35326090 Free PMC article. Review.
-
Antifungal and Larvicidal Activities of Phlorotannins from Brown Seaweeds.Mar Drugs. 2021 Apr 16;19(4):223. doi: 10.3390/md19040223. Mar Drugs. 2021. PMID: 33923448 Free PMC article. Review.
-
Marine Alga Ulva fasciata-Derived Molecules for the Potential Treatment of SARS-CoV-2: An In Silico Approach.Mar Drugs. 2022 Sep 19;20(9):586. doi: 10.3390/md20090586. Mar Drugs. 2022. PMID: 36135775 Free PMC article.
-
The Potency of Seaweed Sulfated Polysaccharides for the Correction of Hemostasis Disorders in COVID-19.Molecules. 2021 Apr 29;26(9):2618. doi: 10.3390/molecules26092618. Molecules. 2021. PMID: 33947107 Free PMC article. Review.
References
-
- World Health Organization. Director-General's opening remarks at the media briefing on COVID-19–11 March. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening-re....
-
- Islam MT, Sarkar C, El-Kersh DM, et al. Natural products and their derivatives against coronavirus: A review of the non-clinical and pre-clinical data. Phytoter Res. 2020;34:2471–2492. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous